Adhering to the service tenet of "Integrity, Innovation, Harmony, and Win-win", We have established a complete one-stop procurement and comprehensive solution service system.
Mazdutide is a dual agonist
of the GLP-1receptor and glucagon receptor. It is an
analog of oxyntomodulin (OXM).
The drug is developed by Eli Lilly and is
currently in multiple Phase III studies.
In
May 2025, a result of Phase III study has shown that once-weekly mazdutide led
to clinically relevant reductions in body weight in Chinese adults with
overweight or obesity.
packing & Delivery
Product packaging
We have cooperated with experienced shipping forwarders for many years, they arrange the shipment. No matter by express, by air or by sea, we will track the course of the goods all the way, to make sure goods arrive at you on time and in good condition.
Send A Message
We'd love to hear from you if you have any questions!
Related Products
Lemon Bottle
Survodutide
Mazdutide
BPC 157 10mg+GHK-CU 50mg+TB500 10mg